Asymmetry Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Asymmetry Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-150,001	Closed	-$8.93M	–	38
2021 Q3	$8.93M	Buy	150,001 +7,755	+5%	+$458K	5.37%	7
2021 Q2	$9.7M	Sell	142,246 -20,889	-13%	-$1.36M	6.67%	4
2021 Q1	$11.3M	Buy	163,135 +61,890	+61%	+$4.76M	5.86%	5
2020 Q4	$7.78M	Buy	101,245 +7,937	+9%	+$595K	3.55%	11
2020 Q3	$6.98M	Sell	93,308 -79,588	-46%	-$5.31M	4.49%	9
2020 Q2	$10.9M	Sell	172,896 -76,970	-31%	-$4.24M	8.34%	2
2020 Q1	$10.5M	Buy	249,866 +207,178	+485%	+$9.5M	11.48%	1
2019 Q4	$1.94M	Buy	42,688 +26,416	+162%	+$1.25M	3.48%	10
2019 Q3	$745K	Buy	+16,272	New	+$915K	1.6%	20

Other funds holding ARNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Asymmetry Capital Management's ARNA Position: Q4 2021 in Review

Asymmetry Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 150,001 shares — an estimated $8.93M sold.

Asymmetry Capital Management first reported a position in ARNA in Q3 2019 and held it in 9 quarters. The position peaked at $11.3M in Q1 2021. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

Asymmetry Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
Asymmetry Capital Management sold 150,001 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $8.93M.
Asymmetry Capital Management first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 9 quarters.
Asymmetry Capital Management's Arena Pharmaceuticals Inc position peaked at $11.3M in Q1 2021.
316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Asymmetry Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.